- Home
- MEDP vs HSIC Comparison
MEDP vs HSIC Comparison
Compare MEDP & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- HSIC
- Stock Information
- Founded
- MEDP 1992
- HSIC 1932
- Country
- MEDP United States
- HSIC United States
- Employees
- MEDP N/A
- HSIC N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- HSIC Medical Specialities
- Sector
- MEDP Health Care
- HSIC Health Care
- Exchange
- MEDP Nasdaq
- HSIC Nasdaq
- Market Cap
- MEDP 10.5B
- HSIC 8.7B
- IPO Year
- MEDP 2016
- HSIC 1995
- Fundamental
- Price
- MEDP $337.35
- HSIC $73.22
- Analyst Decision
- MEDP Buy
- HSIC Buy
- Analyst Count
- MEDP 10
- HSIC 9
- Target Price
- MEDP $389.00
- HSIC $79.56
- AVG Volume (30 Days)
- MEDP 226.7K
- HSIC 990.3K
- Earning Date
- MEDP 02-10-2025
- HSIC 02-25-2025
- Dividend Yield
- MEDP N/A
- HSIC N/A
- EPS Growth
- MEDP 33.84
- HSIC N/A
- EPS
- MEDP 11.42
- HSIC 2.42
- Revenue
- MEDP $2,070,866,000.00
- HSIC $12,499,000,000.00
- Revenue This Year
- MEDP $13.95
- HSIC $6.16
- Revenue Next Year
- MEDP $5.49
- HSIC $3.70
- P/E Ratio
- MEDP $29.49
- HSIC $29.59
- Revenue Growth
- MEDP 16.24
- HSIC N/A
- 52 Week Low
- MEDP $286.76
- HSIC $63.67
- 52 Week High
- MEDP $459.77
- HSIC $82.63
- Technical
- Relative Strength Index (RSI)
- MEDP 47.28
- HSIC 57.16
- Support Level
- MEDP $327.00
- HSIC $70.35
- Resistance Level
- MEDP $359.63
- HSIC $72.44
- Average True Range (ATR)
- MEDP 9.20
- HSIC 1.54
- MACD
- MEDP -0.72
- HSIC 0.34
- Stochastic Oscillator
- MEDP 31.73
- HSIC 94.20
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.